z-logo
open-access-imgOpen Access
Case report: successful retreatment of hepatitis C genotype 1b infection with sofosbuvir + simeprevir in a patient with cirrhosis who had prior virologic relapse after treatment with daclatasvir and asunaprevir
Author(s) -
Safadi Rifaat,
Noviello Stephanie,
Boparai Navdeep,
McPhee Fiona
Publication year - 2016
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.581
Subject(s) - daclatasvir , simeprevir , sofosbuvir , medicine , hepatitis c , cirrhosis , hepatitis c virus , virology , gastroenterology , ribavirin , virus
Key Clinical Message There is currently minimal clinical experience regarding retreatment options for patients failing direct‐acting antiviral combination regimens. Here, we report the outcomes of a HCV genotype 1b‐infected patient with virologic failure following treatment with daclatasvir and asunaprevir, who was successfully retreated with sofosbuvir plus simeprevir.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here